This document provides an overview of various types of headaches presented by Dr. Yasam Jeji Maheswara Sai. It defines headaches and classifies them as primary or secondary. Primary headaches include migraines, tension-type headaches, and cluster headaches. The document discusses the pathogenesis and treatment of various primary headaches. It also covers secondary headaches that can be caused by conditions like meningitis, brain tumors, or glaucoma. Red flags are provided to help identify potential secondary causes of new onset headaches.
A talk covering epidemiology, diagnosis and management of primary headache disorders, common cases of secondary headache disorders and when to order brain imaging, lumbar puncture in headaches.
A talk covering epidemiology, diagnosis and management of primary headache disorders, common cases of secondary headache disorders and when to order brain imaging, lumbar puncture in headaches.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
1. Headache
presentation by
Dr Yasam Jeji Maheswara Sai
1st yr Post Graduate
MD General Medicine
Moderator
Dr T Mouleswara kumar
Associate Professor
General Medicine
MIMS
Dr P.CH. Mishra
Proff & HOD
Department of General Medicine
MIMS
2. Definition : pain or discomfort in the head or upper neck region, the pain originates from
tissues and structures that surround brain or skull
International headache society
Primary Headche – headache features are disorder itself
which often results in considerable disability and ↓QUALY
Secondary Headache -- exogenous disorders which are mostly by URTI and are rarely .
worrisome
3.
4.
5. Origin
Stimulated nociceptors due to
Tissue injury
visceral distension
other factors
damage pain producing pathway
central
peripheral
7. Primary Headache
Involves - Trigemino vascular complex
Large intracranial vessels
dural mater
peripheral nerves of trigeminal nerve
Pathway 5th CN + C1 C2 nerve roots --trigeminocervical complex
Dorsal horns of upper cervical spinal cord
caudal portion of trigeminal nerve
ventroposteromedial thalamus
cortex
8. Modulation
from trigeminal nociceptors at all levels of pain pathway
via Hypothalamus and brainstem structures
Trigeminal autonomic cephalalgias ( TACs ) symptoms
lacrimation
conjunctival injection
Nasal congestion
rhinorrhea
periorbital swelling
aural fullness
ptosis
9. Primary headaches are not vascular
headaches
Migraine and other primary headaches
Do not manifest vascular changes
Treatment outcomes cannot be predicted by vascular effects
10. Approach to New Onset Headache
In New onset headache probability of potential serious cause is greater than than
reccurent headaches when red flag signs are present
History and examination
cranial arteries palpation
passive cervical spine movement
cvs and renal status
BP monitoring ,CUE
fundoscopy , IOP management , refraction
Checklist of red flags
MRI / CT
LP if advised by physician
Psycological consulation at last to r/o depression and anxiety as their relation exits with
headpain
11. Clues to identify secondary
ICH --- SAH
acute < 5 min
severe > 5 min
stiff neck but no fever
----ruptured aneurysm , Av malf ,intraparenchymal H”Ge
high BP in majority cases
present with headache alone
---- CT can miss
small H’Ge
below foramen magnum
12. Meningitis
stiff neck with fever
acute , severe Headache
accentuation of pain with eye movement
MISTAKEN FOR MIGRAINE
LP is mandatory
Brain tumor --- 30% patients presents with chief complaint of headache
intermittent deep dull aching moderate intensity
worsen with exertion / positional change
asso with nausea & vomiting
sleep disturbances
vomiting precedes Headache
13. Amenorrhea/ Galactorea
prolactin secreting pituitary adenoma
Malignancy – cerebral metastasis
ca meningitis or both
Pain after bending , lifting or coughing
post fossa mass
chiari malformation
low CSF volume
14. Glaucoma - HA start with severe eye pain
asso with nausea & vomiting
eye is often red with fixed dilated pupil
Gaint cell arteritis – elderly female
pain increases gradually over few hours before the peak . .
. intensity is reached
explosive occasionally
dull and boring type
polymyalgia rheumatica
jaw claudicaton
fever , weight loss
scalp tenderness
difficulty to comb or rest over the pillow
red tender nodules , streaky red skin
50 % develop blindness
high ESR / CRP but not always
15.
16. Medication – overuse Headache
Medication overuse Can aggravate headache frequency
Markedly impair the effect of preventive medicines
State of refractory daily or near daily headache
On stopping analgesics
substantial improvement in the severity and frequency
especially with opioids or barbiturates
17. OPD management
Analgesic to be reduced & eliminated
reduce dose by 10% every 1-2 weeks
Rescue for residual effect
a small dose NASIDS is not a problem for patients
Once patient has reduced the analgesic use substantially
preventive medication is to be introduced
18. IPD management
Day 1 Acute medication are withdrawn
hydration and antiemetics are to be administered as required
. Clonidine for opiod withdrawl symptoms
If pain is intolerable
aspirin 1g IV , chlorpromazine IM at night
Day 3-5 withdrawl symptoms disappear
IV ( DHE ) dihydroerogotamie TID _ 5 days
induces significant remission
that allows a preventive medicine to be established
19. Primary chronic daily Headache
MCA (monoclonal antibody) to CGRP or its receptor
effective in chr Migraine in phase II/ III RCT over placebo
Non invasive neuro modulatory approaches
single pulse transcranial magnetic stimulation
Non invasive vagal nerve stimulation
modulate thalamic processing / brainstem mechanism respectively
chronic cluster headache
chronic paroxysomal hemicrania
SUNA & SCUNT
20. NEW DAILY PERSISTANT HEADACHE
Headache in all days
Onset
begins abruptly
patient can clearly recall the moment of onset
Evolves over 3 days – to the max upper limit possible
priority is to distinguish primary / secondary cause
21.
22. Low CSF volume Headache
Onset :
headache from day 1 to the next day
generally not present on waking but worsens during the day
Positional
begins when pt sits or stands upright
resolves on reclining
Site and character
occipitofrontol
dull ache but may be throbbing
23. Etiology of low CSF vol headache
CSF leak following LP ( most common )
10-30 % incidence
begins in 48hrs can be delayed upto 12 days
temporary relief with caffeine beverages
epidural injection
vigorous valsalva such as lifting , straining , coughing , clearing ET in airplane
DD – postural orthostatic tachycardia syndrome
24. Mechanism :
low volume rather low pressure
IOC :
MRI with gadolinium – shows diffuse meningeal enhancement
MRI spine with T2 weighting – reveals leak
Source of leak
spinal MRI with appropriate sequences
CT
MR myelography
111 In-DTPA csf study
25. Management
bed rest initially
if pain is persistant ‘
IV caffeine 500mg in 500ml NS @ 2hr
ECG to screen arrhythmia before administering
if needed caffeine can be given twice before going for additional test
If unsuccessful ---- abdominal binder
If interactable ---- oral theophylline
If leak identified --- autologous blood patch
26. Headache of raised ICT
Generalise headache
present on waking up
improves as the day goes on
worsen with recumbency
Visual obscurations are frequent
Dx straightforward if papilledema
possible even in pt without fundoscopic changes
frontal visual field testing helps
DD ---uncontrolled HTN , OSA
27. Investigation
MRI with MR Venogram
CSF pressure on removal of 20-30 ml
Management :
Acetazolamide 250-500 mg BD ---improves in weeks
if ineffective : Topiramate
CA inhibitor , weight loss
neuronal membrane stabilization
if still refractory :
ICP monitoring and may require shunting
28. Post traumatic headache
Injury / Infection/ surgery / SAH
can trigger headache
last for month or year after the event with
dizziness , vertigo , impaired memory
May remit after several weeks / months / years after injury
CNS examination is normal
CT /MRI are unreavealing
Mimc --- SDH
29.
30.
31. Migraine
Most common headache related and indeed
neurologic cause of disability in the world
2nd most common cause of headache
32. Pathogenesis of migraine
sensory sensitivity that is characteristic of migraine is probably due to dysfunction
of monoaminergic sensory control systems located in the brainstem and
hypothalamus
Activation of cells in the trigeminal nucleus results in the release of calcitonin
gene–related peptide (CGRP), at vascular terminals of the trigeminal nerve and
within the trigeminal nucleus.
the involvement of the neurotransmitter 5-hydroxytryptamine (5-HT; also known
as serotonin)is seen
33. Brainstem pathway that modulate sensory input
Trigeminovascular input from meningeal vessels
passes through trigeminal ganglion , synapses on 2nd order neuron in TCC
these neurons project into quintothalamic tract
after decussating in brainstem , synapses with neurons in thalamus
Important modulation of Trigeniovascular nociceptive input
comes from dorsal raphe nucleus , locus ceruleus and nucleus raphae magnus
34.
35. Migraine genetics Familial hemiplegic migraine(FHM)
FHM 1 ___: cav2.1 (P/Q) type voltage gated ca channel CACNA1A
FHM2 ---- Na K ATPase gene
FHM3 ___neuronal voltage gated Na channel SCN1A
Functional neuroimaging :
brain stem involvement in migraine
posterior hypothalamic gray matter region suprachiasmatic nucleus in
. cluster headache
36.
37.
38.
39.
40. Non pharmacological treatment
Avoid trigger _ when pt can identify triggers
A regulated lifestyle
healthy diet , regular exercise
regular sleep patterns
avoid excess caffine / alcohol
avoid stress
Practical tip : lower the avoidable stress by Yoga, meditation , hypnosis
conditioning techniques such as biofeedback
49. Acute attack of cluster headache
Mostly nocturnal ,unilateral , periodicity
O2 inhalation 10-12 L/min for 15-20 min
sumatriptan 6mg s/c rapid onset shorten attack to 10-15 min
Suminat 20 & zolmitriptan 5mg nasal sprays
nVNS
2min stimulation cycles applied consequetively at the onset of .headache on side of pain
can be repeated after 9min
Preventive measures :
limited use of glucocorticoids
greater occipital nerve injection with glucocorticoids , lidocaine
50.
51. Primary paroxysmal hemicrania
M: F – 1:1
Site tends to be retroorbital ,can be seen all over the head
Features : unilareral
very severe pain
short lasting attacks 2-45 min
very frequent attacks >5 /day
marked autonomic features ipsilateral to pain are seen
rapid course < 72hrs excellent response to indomethacin
nVNS can be useful
52. Secondary paroxysmal hemicrania
Lesions in
sella turcica
Av malformation
cavernous sinus meningioma
pituitary pathology
epidermoid tumors
More likely in pt requiring high doses of indomethacin > 200mg/day
MRI is indicated to R/o pituitary lesion
53. SUNCT/SUNA
SUNT : severe U/L orbital /temporal pain
stabbing / throbbing quality
diagnosis : require 20 attacks
lasting for 5-240 sec
ipsilateral conjunctival injection & lacrimation
Suspect SUNCT – cutaneous triggers without refractory periods between attacks .
. lack of response to indomethacin
Secondary SUNCT – can be seen in posterior fossa / pituitary lesions
r/o by pituitary function test & MRI brain with pituitary views
54. Treatment :
IV lidocaine which arrest symptoms
can be used in hospitalised pt
Prevention :
lamotrigine 200-400 mg/dl
topiramate & gabapentin can also be used
occipital nerve stimulation
55.
56. Hemicrania continua
Onset 10-70 yrs
women twice affected than men
moderate and continuous
U/L associated with severe pain
ass with autonomic feautures
conjunctival injection , lacrimation , photophobia on affected side
Treatment :
inj indomethacin 100mg IM is diagnostic tool
oral dose of 25mg f/b 50mg /75mg TID can be given
occipital nerve stimulation in pt unable to tolerate indomethacin
57. Primary cough headache
Generalized headache
due to cough
begins shuddenly
last for seconds / several minutes upto few hours
R/O secondary causes
Arnold chairi malformation
any lesion obstructing CSF pathways
cerebral aneurysm , carotid stenosis
vertebrobasilar disease
Treatment :
indomethacin 25-50 mg BD /TID
some may require LP
58. Primary exercise headache
Pulsatile quality of migraine headache
last < 48hr
B/l often throbbing
migraine feautures may be seen
Secondary cause :
cardiac cephalgis - anginal pain refered to head
probably by central connections of vagal afferents
may present as exercise headache
Treatment : Indomethacin at daily doses from 25–150 mg is generally effective.
prevention : Indomethacin (50 mg), a gepant , ergotamine (1 mg orally), and
dihydroergotamine (2 mg by nasal spray) are used.
59. Headache with sexual activity
Mostly in men
3 types
1 b/l in head & neck intensifies on excitement
2 shudden severe explosion occuring at orgasm
3 postural headache after coitus
Secondary causes like SAH in 5-12%
Treatment : propranolol 40-200mg/day
CCB _ diltiazem 60mg TID
Indomethacin 25-50 mg 30-45 min before activity is helpful
60. Primary thunderclap headache
Reversible cerebral segmental vasoconstriction
resolves spontaneously by 12 weeks
Treatment : Nimodipine is useful
DD: sentinel bleed of IC aneurysm
cervico cephalic arterial dissection
cerebral venous thrombosis
pheochromocytoma
pt on MAOIs taking sympatomimitic drug / thiamine containing food cheese
reaction
61. Cold stimulus headache
Ingestion / inhalation of cold substance
resolves in 10-30 min of stimulus withdrawl
TRPM 8 –transient receptor potential cation subfamily M member 8
cold temperature sensor
this mediate this syndrome
62. External pressure headache
Headache stimulus Due to external pressure like helmets, swimming
goggles or very long ponytails
Treatment : recognise and remove the problem
63. Primary stabbing headache
Ice pick pains / jabs & jolts
Last for 1 to many seconds
occurs as a single stab or series of stabs
Absent
cranial autonomic feature
cutaneous triggering
Reccurent type at irregular interval (hours to days)
Treatment : indomethacine 25-50 mg BD/ TID is excellent
64. Nummular headache
Continuous/ intermittent type
in a fixed place of 1-6 cm size elliptical discomfort
associated with allodynia / hypesthesia
Treatment : tricyclics like amitriptyline
anticonvulsants like topiramate / valproate
65. Hypnic headache
After 6o years age mostly female
Begins few hrs after sleep
2 * Due to poor control of HTN so 24hr BP monitoring is required
Headache for 15-30 min can be throbbing unilateral ..upto 3 times/night
Migraine features are not seen
Treatment lithium carbonate 200-600 mg HS
or verapamil 160mg Hs
1 / 2 cups coffe or 6omg caffeine po is effective
others like flunarizine 5mg HS / indomethacine 25-75 mg HS